AIM ImmunoTech Inc.
AIMI----
Q1 FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.03.31
Overview: AIM ImmunoTech Inc.(AIMI) the Revenue is 16 K (-60%);the EBIT is -3.619 M (+36.89%);the EPS is -0.0527 (+55.21%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B60.00%
----
----
EBIT
-0.00B36.89%
----
----
EPS
-0.052755.21%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf